Neuroimmune mechanisms of type 2 inflammation in the skin and lung

Type 2 inflammation has a major role in barrier tissues such as the skin and airways and underlies common conditions including atopic dermatitis (AD) and asthma. Cytokines including interleukin 4 (IL-4), IL-5, and IL-13 are key immune signatures of type 2 inflammation and are the targets of multiple...

Full description

Saved in:
Bibliographic Details
Main Authors: Masato Tamari, Aaron M. Ver Heul
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Allergology International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1323893025000115
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849388401029021696
author Masato Tamari
Aaron M. Ver Heul
author_facet Masato Tamari
Aaron M. Ver Heul
author_sort Masato Tamari
collection DOAJ
description Type 2 inflammation has a major role in barrier tissues such as the skin and airways and underlies common conditions including atopic dermatitis (AD) and asthma. Cytokines including interleukin 4 (IL-4), IL-5, and IL-13 are key immune signatures of type 2 inflammation and are the targets of multiple specific therapeutics for allergic diseases. Despite shared core immune mechanisms, the distinct structures and functions of the skin and airways lead to unique therapeutic responses. It is increasingly recognized that the nervous system has a major role in sensing and directing inflammatory processes. Indeed, crosstalk between type 2 immune activation and somatosensory functions mediates tissue-specific signatures such as itching in the skin. However, neuroimmune interactions are shaped by distinct neuronal and immune landscapes, and differ between the skin and airways. In the skin, dorsal root ganglia-derived neurons mediate pruritus via type 2 cytokines and neurogenic inflammation by mast cell or basophil activation. Conversely, vagal ganglia-derived neurons regulate airway immune responses by releasing neuropeptides/neurotransmitters such as calcitonin gene-related peptides, neuromedin U, acetylcholine, and noradrenaline. Sensory neuron-derived vasoactive intestinal peptide forms a feedback loop with IL-5, amplifying eosinophilic inflammation in the airways, a mechanism that is absent in the skin. These differences influence the efficacy of cytokine-targeted therapies. For instance, IL-4/IL-13-targeted therapies like dupilumab demonstrate efficacy in AD and allergic airway diseases, whereas IL-5-targeted therapies are effective in eosinophilic asthma but not AD. Understanding these neuroimmune interactions underscores the need for tailored therapeutic approaches to address allergic diseases where barrier tissues are involved.
format Article
id doaj-art-01178fc7a9534c3eac39529aeb048ea8
institution Kabale University
issn 1323-8930
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series Allergology International
spelling doaj-art-01178fc7a9534c3eac39529aeb048ea82025-08-20T03:42:19ZengElsevierAllergology International1323-89302025-04-0174217718610.1016/j.alit.2025.02.001Neuroimmune mechanisms of type 2 inflammation in the skin and lungMasato Tamari0Aaron M. Ver Heul1Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan; Corresponding author. Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Setagayaku, Tokyo, 157-8535, Japan.Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St. Louis, USA; Corresponding author. Division of Allergy and Immunology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63130, USA.Type 2 inflammation has a major role in barrier tissues such as the skin and airways and underlies common conditions including atopic dermatitis (AD) and asthma. Cytokines including interleukin 4 (IL-4), IL-5, and IL-13 are key immune signatures of type 2 inflammation and are the targets of multiple specific therapeutics for allergic diseases. Despite shared core immune mechanisms, the distinct structures and functions of the skin and airways lead to unique therapeutic responses. It is increasingly recognized that the nervous system has a major role in sensing and directing inflammatory processes. Indeed, crosstalk between type 2 immune activation and somatosensory functions mediates tissue-specific signatures such as itching in the skin. However, neuroimmune interactions are shaped by distinct neuronal and immune landscapes, and differ between the skin and airways. In the skin, dorsal root ganglia-derived neurons mediate pruritus via type 2 cytokines and neurogenic inflammation by mast cell or basophil activation. Conversely, vagal ganglia-derived neurons regulate airway immune responses by releasing neuropeptides/neurotransmitters such as calcitonin gene-related peptides, neuromedin U, acetylcholine, and noradrenaline. Sensory neuron-derived vasoactive intestinal peptide forms a feedback loop with IL-5, amplifying eosinophilic inflammation in the airways, a mechanism that is absent in the skin. These differences influence the efficacy of cytokine-targeted therapies. For instance, IL-4/IL-13-targeted therapies like dupilumab demonstrate efficacy in AD and allergic airway diseases, whereas IL-5-targeted therapies are effective in eosinophilic asthma but not AD. Understanding these neuroimmune interactions underscores the need for tailored therapeutic approaches to address allergic diseases where barrier tissues are involved.http://www.sciencedirect.com/science/article/pii/S1323893025000115CytokineNeuroimmune interactionNeuropeptideNeurotransmitterPeripheral nervous system
spellingShingle Masato Tamari
Aaron M. Ver Heul
Neuroimmune mechanisms of type 2 inflammation in the skin and lung
Allergology International
Cytokine
Neuroimmune interaction
Neuropeptide
Neurotransmitter
Peripheral nervous system
title Neuroimmune mechanisms of type 2 inflammation in the skin and lung
title_full Neuroimmune mechanisms of type 2 inflammation in the skin and lung
title_fullStr Neuroimmune mechanisms of type 2 inflammation in the skin and lung
title_full_unstemmed Neuroimmune mechanisms of type 2 inflammation in the skin and lung
title_short Neuroimmune mechanisms of type 2 inflammation in the skin and lung
title_sort neuroimmune mechanisms of type 2 inflammation in the skin and lung
topic Cytokine
Neuroimmune interaction
Neuropeptide
Neurotransmitter
Peripheral nervous system
url http://www.sciencedirect.com/science/article/pii/S1323893025000115
work_keys_str_mv AT masatotamari neuroimmunemechanismsoftype2inflammationintheskinandlung
AT aaronmverheul neuroimmunemechanismsoftype2inflammationintheskinandlung